TGX-115 ( —— )

产品货号. M34039 CAS No. 351071-62-0

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

TGX-115
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

TGX-115 is a cell-permeable and potent inhibitor of the PI 3-K isoform p110β/p110δ (IC50 values of 0.13 μM for p110β and 0.63 μM for p110δ), an enzyme that regulates platelet adhesion and inhibits phosphoinositide (PI) 3-kinase, and can be used to treat coronary artery occlusion, stroke, acute coronary artery It can be used to treat cardiovascular diseases such as coronary occlusion, stroke, acute coronary syndrome, acute myocardial infarction, restenosis, atherosclerosis and unstable angina.
产品描述

TGX-115 is a cell-permeable and potent inhibitor of the PI 3-K isoform p110β/p110δ (IC50 values of 0.13 μM for p110β and 0.63 μM for p110δ), an enzyme that regulates platelet adhesion and inhibits phosphoinositide (PI) 3-kinase, and can be used to treat coronary artery occlusion, stroke, acute coronary artery It can be used to treat cardiovascular diseases such as coronary occlusion, stroke, acute coronary syndrome, acute myocardial infarction, restenosis, atherosclerosis and unstable angina.
体外实验

——
体内实验

——
同义词

——
通路

PI3K/Akt/mTOR signaling
靶点

PI3K
受体

PI3K
研究领域

——
适应症

——

计算器

产品手册

关联产品

MOMIPP

MOMIPP 是 PIKfyve 抑制剂和巨胞饮诱导剂。 MOMIPP 很容易穿透血脑屏障，并且在抑制脑内胶质母细胞瘤异种移植物的进展方面具有中等效果。
SAR260301

SAR260301 (SAR-260301, SAR 260301) 是一种有效的、选择性的、ATP 竞争性 PI3Kβ 抑制剂，在 TR-FRET 测定中 IC50 为 52 nM。
STX-478

STX-478 (化合物 80) 是一种口服有效的、具有血脑屏障透过性的、突变选择性变构 PI3Kα 抑制剂。STX-478 能稳健且持久地使肿瘤消退，可用于癌症的研究。